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OBJECTIVE: This study aimed to determine the frequency of the PROGINS polymorphism in women with
endometriosis-associated infertility, in infertile women without endometriosis and in controls.
INTRODUCTION: The human progesterone receptor gene has two isoforms that modulate the biological action of
progesterone: isoform A, which is capable of inhibiting the activation of the estrogen receptors, and isoform B,
which has the capacity to activate the estrogen receptors. Several polymorphisms have been described for this gene,
among which one stands out: a polymorphism named PROGINS, which has been speculated to be related to the
genesis of endometriosis by several studies with conflicting results.
METHODS: This was a prospective study that included 148 patients with endometriosis-associated infertility, 50
idiopathic infertile patients and 179 fertile women as controls. The PROGINS polymorphism was studied by PCR.
RESULTS: Genotypes P1P1, P1P2 and P2P2 (P2 representing the PROGINS polymorphism) of the progesterone
receptor gene presented frequencies of 93.9%, 5.4% and 0.7%, respectively, in the women with endometriosis-
associated infertility (p = 0.2101, OR = 0.51, 95% CI = 0.24-1.09); 94.4%, 4.2% and 1.4%, respectively, in the patients
with minimal/mild endometriosis (p = 0.2725, OR = 0.53, 95% CI = 0.20-1.43); 93.5%, 6.5% and 0%, respectively,
among the patients with moderate/severe endometriosis (p = 0.3679, OR = 0.49, 95% CI = 0.18-1.31); 86.0%, 14.0%
and 0%, respectively, in idiopathic infertile women (p = 0.8146, OR = 1.10, 95% CI = 0.46-2.63); and 88.3%, 10.6%
and 1.1%, respectively, in the control group.
CONCLUSION: The data suggest that PROGINS is not related either to endometriosis-associated infertility or to
idiopathic infertility in the population studied.
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INTRODUCTION
Endometriosis is a common disease defined as the growth
of endometrial tissue outside the uterine cavity and results
in a vast array of gynecological problems including
dyspareunia, dysmenorrhea, pelvic pain and infertility.1,2
Several studies have revealed a large number of genetic
markers related to immune, neuroendocrine and reproduc-
tive functions present in high frequency among patients
with endometriosis, indicating associations between the
development of endometriosis and genetic polymorph-
isms.3-6
Progesterone is a potent antagonist of estrogen-induced
proliferation in the endometrium and may play a pivotal
role in the pathogenesis of endometriosis. The human
progesterone receptor gene is located at chromosome
11q22-23 and has two isoforms that modulate the biological
action of progesterone: isoform A, which is capable of
inhibiting the activation of the estrogen receptors, and
isoform B, which has the capacity to activate the estrogen
receptors.7 Several polymorphisms have been described for
this gene, among which one stands out: a polymorphism
named PROGINS, which arises due to the insertion of an
Alu element into intron G between exons 7 and 8 of isoform
A of the PR gene, resulting in an increase of 306 bp in the
gene product.8
Wieser et al.9 studied 95 women with endometriosis and
107 women without endometriosis and concluded that the
PROGINS polymorphism is associated with susceptibility to
endometriosis. Similarly, Lattuada et al.10 studied the
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PROGINS polymorphism in 131 women with endometriosis
and a control group of 127 women and confirmed the
relationship between this polymorphism and endometriosis.
Similar results were also obtained by Carvalho et al.11 On
the other hand, Govindan et al.12 tested 445 Indian women:
100 had endometriosis, 80 had uterine fibrosis, 157 had
breast cancer, and 108 served as a control group. These
authors concluded that the PROGINS polymorphism can be
considered a risk marker for breast cancer but not for
endometriosis or uterine fibrosis.
Thus, the objective of the present study was to determine
the frequency of the progesterone receptor gene polymorph-
ism PROGINS in women with endometriosis-associated
infertility or idiopathic infertility and in controls.
MATERIAL AND METHODS
Patients
Among the patients of the Human Reproduction Service
of the Faculdade de Medicina do ABC (FMABC), 148
patients with endometriosis-associated infertility (mean age:
34.4 ¡ 4.2 years) diagnosed by laparoscopy and classified
by histological criteria according to the American Society for
Reproductive Medicine13 and 50 idiopathic infertile women
(mean age: 35.5¡ 3.1 y) were selected. In the endometriosis
group, 48.0% (71/148) had minimal/mild endometriosis,
and 52.0% (77/148) had moderate/severe endometriosis.
For the control group, 179 fertile women (mean age: 39.7¡
4.8 years) who had undergone tubal ligation, which allowed
confirmation of the absence of endometriosis, were selected
from the Family Planning Outpatient Clinic of the FMABC.
The cause of infertility was investigated according to the
minimum propaedeutic of the infertile couple: hormonal
and biochemistry profiles, serum testing, sexually trans-
mitted disease investigations, imaging examinations, inves-
tigations of genetic and/or immunological abnormalities,
hysterosalpingography, hysteroscopy, laparoscopy (laparo-
scopy was performed in all women up to 36 years old and in
patients over 36 years old when there were symptoms or
imaging examinations abnormalities) and seminal analysis.
In the absence of abnormalities in any of these exams, the
infertility was considered idiopathic. Patients with endome-
triosis who did not achieve pregnancy after at least six
natural or induced cycles following laparoscopy were
considered infertile. All women whose partner had mascu-
line factors involved with the infertility were excluded from
the study.
Clinical data and peripheral blood samples were collected
only after explaining the objectives of the study and obtaining
a signed informed consent form, as approved by the local
Research Ethics Committee (CEP FMABC No. 293/2007).
Methods
DNA Extraction
Peripheral blood was collect from each patient and control
in an EDTA-containing tube. Genomic DNA was extracted
from lymphocytes in the peripheral blood using an illustra
blood genomicPrep Mini Spin Kit, according to the manu-
facturer’s instructions (GE Healthcare Life Sciences, USA).
PCR
Molecular analysis of the PROGINS progesterone recep-
tor gene polymorphism was performed according to the
protocol of Wieser et al.9 with modifications. The primers
used were 59-GGC AGA AAG CAA AAT AAA AAG A-39
(forward) and 59-AAA GTA TTT TCT TGC TAA ATG TC-39
(reverse).
The PCR reaction was carried out in a final volume of
25 ml, containing 1X buffer, 2.5 mM MgCl2, 0.1 mM of each
dNTP, 50 nM of each primer, 1 U of Taq Polymerase
(Invitrogen), and 200 ng of DNA. Amplification was
performed with an initial denaturation step at 95 C˚ for
7 min, followed by 35 cycles of denaturation at 95 C˚ for
45 sec, annealing at 50 C˚ for 1 min, and extension at 72 C˚
for 1 min and a final extension step at 72 C˚ for 7 min. The
amplification product was visualized in a 1% agarose gel
under UV light.
The PCR product presented a single band of 149 bp in the
homozygous individuals without the mutation, designated
as P1P1. The presence of one 149-bp and one 455-bp band
indicated heterozygous individuals, who have one allele
without the mutation and one allele with the mutation;
these individual were designated as P1P2. The presence of a
single 455-bp band indicated individuals with the mutation
in both alleles, and these individuals were designated as
P2P2.
Statistical analysis
Allele and genotype frequencies were compared between
groups using the x2-test or the Fisher’s exact test. All p-
values were two-tailed, and 95% confidence intervals (CIs)
were calculated. A p-value , 0.05 was considered statisti-
cally significant.
RESULTS
The genotype and allele frequencies of the PROGINS
polymorphism in patients with endometriosis-associated
infertility or idiopathic infertile patients and in the control
group are summarized in Table 1.
The frequencies of genotypes P1P1, P1P2 and P2P2 of the
PROGINS polymorphism in the patients with endometrio-
sis-associated infertility were 93.9% (139/148), 5.4% (8/148)
and 0.7% (1/148), respectively (p = 0.2101). Among the
women with minimal/mild endometriosis, 94.4% (67/71)
presented the normal homozygous genotype P1P1, 4.2% (3/
71) had the heterozygous genotype P1P2, and 1.4% (1/71)
showed the mutated homozygous genotype P2P2
(p = 0.2725). In the patients with moderate/severe endome-
triosis, the frequencies of genotypes P1P1, P1P2 and P2P2
were 93.5% (72/77), 6.5% (5/77), and 0%, respectively
(p = 0.3679). In idiopathic infertile women, the genotypes
P1P1, P1P2 and P2P2 were observed in 86.0% (43/50), 14.0%
(7/50) and 0% of women, respectively (p = 0.8146). In the
control group, 88.3% (158/179) presented the normal
homozygous genotype P1P1, 10.6% showed (19/179) the
heterozygous genotype P1P2, and 1.1% (2/179) had the
homozygous mutated genotype (Table 1).
Considering the alleles, allele P1 was present in 96.6% of
patients with endometriosis-associated infertility, in 96.5%
of women with minimal/mild endometriosis, in 96.8%
patients with moderate/severe endometriosis, in 93.0% of
idiopathic infertile women and in 93.6% of the control
group. Allele P2, on the other hand, was present in 3.4% of
patients with endometriosis-associated infertility
(p = 0.1117, OR = 0.51, 95% CI = 0.24-1.09), in 3.5% of women
with minimal/mild endometriosis (p = 0.2899, OR = 0.53,
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95% CI = 0.20-1.43), in 3.2% patients with moderate/severe
endometriosis (p = 0.2161, OR = 0.49, 95% CI = 0.18-1.31), in
7.0% of idiopathic infertile women (p = 1.0, OR = 1.10, 95%
CI = 0.46-2.63) and in 6.4% of the control group.
The power calculations for the groups of women with
endometriosis-associated infertility and idiopathic infertility
were 0.80, a= 0.05, and ,0.50, a= 0.05, respectively.
DISCUSSION
The PROGINS polymorphism produces a decrease in the
stability of the progesterone receptor gene, causing the
receptor to lose its capacity to inhibit the activation of the
estrogen receptors. This in turn results in an inadequate
control of these receptors, thus rendering the endometrium
more vulnerable to the action of estrogen. It is believed that
isoform A can lead to increased expression of isoform B
(which is responsible for the activation of the estrogen
receptors) when it includes the PROGINS polymorphism,
thereby contributing to a higher oncogenic action of this
polymorphism.14 Progesterone is involved in the regulation
of extracellular matrix metalloproteinases, stimulating the
inhibiting factors of these enzymes; it also acts on the
expression of angiogenic factors and on cell cycle-regulating
factors. Moreover, D’Amora et al.15 observed that PROGINS
variants may influence cell proliferation, viability, and
apoptosis in endometrial cell metabolism.
Wieser et al.,9 Lattuada et al.,10 and Carvalho et al.11
demonstrated a significant correlation between the
PROGINS polymorphism and endometriosis. On the other
hand, Govidan et al.12 concluded that the PROGINS
polymorphism can be considered a risk marker for breast
cancer but not for endometriosis or uterine fibrosis.
Additionally, van Kaam et al.16 studied 72 women with
endometriosis, 40 women with adenomyosis in the uterine
wall, 102 gynecological patients without symptomatic
endometriosis and 93 healthy females and concluded that
the PROGINS polymorphism does not seem to modify the
risk of deep-infiltrating endometriosis. In the present study,
the PROGINS polymorphism was present in 6.1% of the
patients with endometriosis-associated infertility and in
11.7% of the women in the control group (p = 0.2101). When
we studied the patients with stage I/II or stage III/IV
endometriosis separately, no statistical difference was found
between groups (p = 0.2725 and p = 0.3679, respectively).
This finding suggests that the PROGINS polymorphism is
not involved in the genesis of the disease in the population
studied (Table 2).
Most of the published studies regarding endometriosis
have used heterogeneous control groups, such as healthy
men and women,17 newborns,18 umbilical cord blood19 and
menopausal women.11 However, the absence of symptoma-
tology in women does not exclude endometriosis, given that
16% of the patients with endometriosis are fertile and
asymptomatic;20 when analyzing newborns and cord blood,
it is possible that the subjects will develop the disease in the
future; and menopause itself produces regression of the
disease in women who may be asymptomatic.
Our control group was carefully selected among fertile
and non-menopausal women who had undergone tubal
ligation for family planning reasons and who had no sign of
endometriosis in their clinical history. Moreover, the
surgeon was able to observe while performing the ligation
that there were no foci of endometriosis in these women.
Table 1 - Frequency of genotypes and alleles of the PROGINS progesterone receptor gene polymorphism in patients
with endometriosis-associated infertility, idiopathic infertile patients and in controls.
Population studied n PROGINS genotypes p values Alleles p values OR (95% CI)
P1P1 (%) P1P2 (%) P2P2 (%) P1 (%) P2 (%)
Endometriosis-associated
infertility patients
148 139 (93.9) 8 (5.40) 1 (0.7) 0.2101 286 (96.6) 10 (3.4) 0.1117 0.51 (0.24-1.09)
Minimal/mild endometriosis 71 67 (94.4) 3 (4.2) 1 (1.4) 0.2725 137 (96.5) 5 (3.5) 0.2899 0.53 (0.20-1.43)
Moderate/severe endometriosis 77 72 (93.5) 5 (6.5) 0 (0.0) 0.3679 149 (96.8) 5 (3.2) 0.2161 0.49 (0.18-1.31)
Idiopathic infertile patients 50 43 (86.0) 7 (14.0) 0 (0.0) 0.6126 93 (93.0) 7 (7.0) 1.000 1.10 (0.46-2.63)
Controls 179 158 (88.3) 19 (10.6) 2 (1.1) 335 (93.6) 23 (6.4)
OR = odds ratio CI = confidence interval
Table 2 - PROGINS progesterone receptor gene polymorphisms in different studies.
Study Population studied Conclusion of the study
Weiser et al.8 95 white women with endometriosis and 107 white women
without endometriosis (controls)
PROGINS appears to be associated with endometriosis in white
persons
Lattuada et al.9 131 Italian women affected by endometriosis and 127 Italian
women without laparoscopic evidence of the disease
PROGINS polymorphism of the progesterone receptor may be
associated with an increased risk of endometriosis
De Carvalho et al.10 121 Women with surgically confirmed endometriosis and 281
controls with normal gynecological exams
PROGINS heterozygosis genotype frequencies were shown to be
statistically higher in women with endometriosis than in
controls
Govidan et al.11 100 Women with endometriosis, 80 women with fibroids and
157 women with breast cancer along with 108 age-matched
normal healthy women as controls
PROGINS can be considered to be a predisposing risk marker for
breast cancer but not for endometriosis or uterine fibroids
van Kaam et al.15 72 women with endometriosis, 40 with adenomyosis in the
uterine wall, 102 gynecological patients without
symptomatic endometriosis and 93 healthy females
The PROGINS polymorphism does not seem to modify the risk of
deep-infiltrating endometriosis
Present study 148 women with endometriosis, 50 idiopathic infertile women
and 179 fertile women without a history of endometriosis
PROGINS is not related either to endometriosis-associated
infertility or to idiopathic infertility in the population studied
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This rigorous selection process of the control group may be
responsible for the high level of significance of the results
obtained.
Clinically, one of the primary concerns regarding endo-
metriosis is its propensity to cause infertility. It is currently
estimated that 25% to 50% of women with endometriosis are
infertile and that 25% to 30% of all infertile women have
endometriotic lesions as the only identifiable cause of their
infertility.1,2 The association between endometriosis and
infertility is well established, but the mechanisms respon-
sible for these effects are unknown. Several hypotheses have
been proposed to explain how endometriosis causes
infertility: 1) pelvic factors, which include adhesions, distort
pelvic anatomy,21 and alter peritoneal function;22 2) ovarian
factors that stem from endocrine and ovulatory disorders
lead to oocyte and embryonic alteration;23 and 3) uterine
factors cause impaired implantation.24 Pisarska et al.25
found an increase in the prevalence of PROGINS mutations
among 26 women with the diagnosis of unexplained
infertility compared to 28 control women (42% vs. 14%);
however, in the current study, the PROGINS polymorphism
was not associated with infertility (14.0% vs. 11.7%). Our
results point to no association between idiopathic infertility
and the PROGINS polymorphism; however, the power
calculation of the sample was low, suggesting that a larger
sample is needed.
It is important to keep in mind that the study was
performed in a special group of patients who underwent
surgery via video laparoscopy and, after surgery, were
exposed for at least twelve months to the possibility of
pregnancy, had no male factor involved in the causes of
infertility and, nevertheless, did not achieve pregnancy.
CONCLUSION
In conclusion, our data suggest that PROGINS is not
related either to endometriosis-associated infertility or to
idiopathic infertility in the population studied. However,
further studies with much larger samples are needed to
confirm the results for the idiopathic infertily group.
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